| Prev Close | 6.84 |
| Day Low/High | 6.73 / 7.22 |
| 52 Wk Low/High | 2.38 / 8.12 |
| Avg Volume | 1.19M |
Ocular Therapeutix Inc. (OCUL)
6.92
NASDAQ : Health Technology
| Exchange | NASDAQ |
| Shares Outstanding | 62.77M |
| Market Cap | 429.37M |
| EPS | -1.90 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
6 Biotech Stocks I'm Looking to Buy as Hot Momentum Cools
My main focus right now is on stronger defense.
The High Level of Skepticism Is Driving This Market
Anyone attempting to navigate this market based on macro-economic analysis is going to have a tough time.
Stock-Picking Is Favorable Now: 4 Names I'm Focused On
A major theme of late has been the outperformance by post-pandemic names in groups such as biotech.
Aggressive Dip Buyers Slow Downside Momentum
The biotech sector doesn't look anything like a bear market.
Small-Caps Are Finally Seeing Some Bottom Fishing
I believe this is just bounce action at this point and not a bottom, but I'm playing it.
This Market Is Almost Totally Driven by the Indices Right Now
The action is not supportive of good chart setups for shorter term trades in individual stocks.
Small-Cap Stocks Keep Traders Bullish: 2 Sectors to Watch
There is nothing in small-caps to suggest that they are as frothy as the big-caps.
3 Languishing Small-Caps That Should Perk Up in 2020
Stemline Therapeutics, Entercom Communications and Ocular Therapeutix offer reasons to think their shares will perform better in the New Year.
Buying Into the Teeth of a Decline
I am inclined to focus more on counter-trend bounces in weak markets.
2 Stocks on My Radar in a Low-Energy Market
Flat markets tend to produce favorable technical setups, but this one may put us to sleep while we wait for further developments.
2 Promising $5 Biotech Stocks to Consider on Recent News
Jounce Therapeutics and Ocular Therapeutix each provided investors with positive news morsels last week.
China Trade Truce, Biotech Fuel Action
Markets continue to be nicely in the black two hours into trading as resumption of U.S.-China trade talks have investors in a good mood to start off the second half of trading in 2019. Some small biotechs continue to show some strength this Monday. ...
Bitcoin: A Trading Opportunity in an Asset With No Intrinsic Value
Its price is determined by emotion more than anything else.
A Summer Friday Has Me Hunting for New Stock Ideas
The important thing to remember on days like this is to not read too much into the action.
Three to Watch in Biotech
Other than the Dow, most of major market indices are showing small gains heading into the last hour of trading. The biotech sector has not participated in today's rally and is down some 0.75% on the day so far. I am watching a few small biotech and ...
Markets Recovering From Latest Trump Tweetstorm
Wall Street discounting talk of bombing Syria from president.
Biotechs Take the Lead This Morning
Whether this market continues to bounce is going to depend a great degree on the FAANG names.
Dip Buyers Are Losing Their Confidence -- And They Have No Interest in Facebook
The longer the stock market goes without a better bounce, the bigger the risk.
You Trading Small-Cap Stocks? You Should Be
Right now this is a market for stock pickers and not timers.
Mid-Afternoon Update
2:15 pm update Markets are pretty much where they were 90 minutes ago. The S&P has strengthened a bit and overall equities have held up better than I thought given the potential partial government shutdown this weekend. We will see if stocks hold th...
These Stocks Are Changing Directions
Bullish and bearish reversals in the market.
3 Small Biotechs on the FDA Summer Calendar
Dynavax Technologies, Ocular Therapeutix and Neos Therapeutics have big drug approval dates ahead.
Keep Biotech Trigger Fingers Holstered
Three names show how fast biotechs can become oversold when the market acts in knee-jerk fashion.
Scanning the Mid-Morning Landscape
The market and 10-year Treasury yield are taking disappointing first-quarter GDP number in stride. The Chicago PMI came in stronger than expected and growth should rebound in the second quarter. Consumer spending was weak in first quarter, especiall...
3 Small Biotechs With Insider Buying
Insiders have an edge in this complex sector, so it's worth checking them out.
